Karina Lidianne Alcântara Saraiva

Suggest Changes
Learn More
The phosphodiesterase type 5 (PDE5) inhibitor, Sildenafil, is a novel, oral treatment approach for pulmonary hypertension. As Leydig cells present PDE5, this study was conducted to investigate the(More)
  • 1